ABBV vs HSIC · P/E 81, rev $16.99B vs P/E 24, rev $6.83B
AbbVie Inc (ABBV) versus Henry Schein Inc (HSIC) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
Henry Schein Inc (HSIC) is a medical distribution company listed on NASDAQ.
Latest reported ABBV revenue for 2026-06-30 was $16.99B. Net income was $3.61B. Revenue was up 13.3% from 2026-03-31 to 2026-06-30. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported HSIC revenue for 2026-06-27 was $6.83B. Net income was $201.0M. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. HSIC currently screens at market cap $9.11B and trailing P/E 24.2.
Not investment advice. Open the ABBV and HSIC stock pages for the full models.
Not investment advice.